| 000 | 01555 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517135947.0 | ||
| 264 | 0 | _c20171103 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a0946-1965 | ||
| 024 | 7 |
_a10.5414/CP202903 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJacob, Louis | |
| 245 | 0 | 0 |
_aPrevalence of bisphosphonate therapy in women with breast cancer treated with aromatase inhibitors in Germany
. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology and therapeutics _cMay 2017 |
||
| 300 |
_a394-396 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAromatase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Prescriptions |
| 650 | 0 | 4 | _aDrug Utilization Review |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 |
_aGuideline Adherence _xtrends |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoporotic Fractures _xchemically induced |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aPractice Patterns, Physicians' _xtrends |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKostev, Karel | |
| 700 | 1 | _aHadji, Peyman | |
| 773 | 0 |
_tInternational journal of clinical pharmacology and therapeutics _gvol. 55 _gno. 5 _gp. 394-396 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5414/CP202903 _zAvailable from publisher's website |
| 999 |
_c26861636 _d26861636 |
||